Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -9.00x is 76% above its 5-year average of -37.62x, near the high end of its 5-year range (-1611.09x–-7.68x).
59.91% above its 12-month average of -22.45x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -31.49x.
INTEREST COVERAGE RATIO
-9.00x
INTEREST COVERAGE RATIO AVG TTM
-22.45x
INTEREST COVERAGE RATIO AVG 3Y
-31.31x
INTEREST COVERAGE RATIO AVG 5Y
-37.62x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+59.91%
CURRENT VS 3Y AVG
+71.25%
CURRENT VS 5Y AVG
+76.08%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.23x
median of 360 covered companies
CURRENT VS SECTOR MEDIAN
-112.77%
vs the sector median at left
HCW Biologics Inc.
Market Cap
$563178.00
Interest Coverage Ratio
-9.00x
TTM Avg
-22.45x
3Y Avg
-31.31x
5Y Avg
-37.62x
Market Cap
$685100.00
Interest Coverage Ratio
-115.23x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$817321.00
Interest Coverage Ratio
-8287.21x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$879845.00
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$885727.00
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$889929.00
Interest Coverage Ratio
N/A
TTM Avg
354.05x
3Y Avg
372.60x
5Y Avg
299.52x
Market Cap
$1.01M
Interest Coverage Ratio
-2.27x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.06M
Interest Coverage Ratio
-290.08x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| HCW Biologics Inc. (HCWB) | $563178.00 | -9.00x | -22.45x | -31.31x | -37.62x |
| CDT Equity Inc. (CDT)vs › | $685100.00 | -115.23x | N/A | N/A | N/A |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $817321.00 | -8287.21x | N/A | N/A | N/A |
| Bone Biologics Corporation (BBLG)vs › | $879845.00 | N/A | N/A | N/A | N/A |
| Decoy Therapeutics Inc. (DCOY)vs › | $885727.00 | N/A | N/A | N/A | N/A |
| GlucoTrack, Inc. (GCTK)vs › | $889929.00 | N/A | 354.05x | 372.60x | 299.52x |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.01M | -2.27x | N/A | N/A | N/A |
| Akanda Corp. (AKAN)vs › | $63114.00 | -5.39x | N/A | N/A | N/A |
| Clearmind Medicine Inc. (CMND)vs › | $1.06M | -290.08x | N/A | N/A | N/A |
| Mobile-health Network Solutions Class A Ordinary Shares (MNDR)vs › | $31004.00 | N/A | N/A | N/A | N/A |
Interest Coverage
-9.0x
Debt/Equity
0.88
Current Ratio
0.06
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -31.49x |
| 2026-03-31 | -29.61x |
| 2025-12-31 | -13.01x |
| 2025-09-30 | -22.98x |
| 2025-06-30 | -15.15x |
| 2025-03-31 | -7.68x |
| 2024-12-31 | -12.74x |
| 2024-09-30 | -16.52x |
| 2024-06-30 | -94.80x |
| 2023-09-30 | -53.16x |
| 2023-06-30 | -47.22x |
| 2023-03-31 | -57.37x |
| 2022-12-31 | -100.77x |
| 2022-09-30 | -124.90x |
| 2022-03-31 | -10.66x |
| 2021-12-31 | -51.11x |
| 2021-09-30 | -1611.09x |
| 2020-12-31 | 6802.34x |
| 2020-09-30 | -7242.33x |
